Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic and Testicular Effects of Testosterone vs hCG in IHH
NCT01601327Phase 4Completed
- Sponsor
- Gulhane School of Medicine
- Start
- Jan 2008
- Primary completion
- Mar 2012
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of testosterone enanthate, Testosterone TEPI patch, human chorionic gonadotropin in idiopathic hypogonadotropic hypogonadism (IHH), sponsored by Gulhane School of Medicine. Started Jan 2008; status: completed.
02
Drugs
testosterone enanthateTestosterone TEPI patchhuman chorionic gonadotropin
03
Conditions
idiopathic hypogonadotropic hypogonadism (IHH)
Beyond the preview
Go deeper on NCT01601327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01601327.